Correlation Between PCI Biotech and Ultimovacs ASA
Can any of the company-specific risk be diversified away by investing in both PCI Biotech and Ultimovacs ASA at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining PCI Biotech and Ultimovacs ASA into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between PCI Biotech Holding and Ultimovacs ASA, you can compare the effects of market volatilities on PCI Biotech and Ultimovacs ASA and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in PCI Biotech with a short position of Ultimovacs ASA. Check out your portfolio center. Please also check ongoing floating volatility patterns of PCI Biotech and Ultimovacs ASA.
Diversification Opportunities for PCI Biotech and Ultimovacs ASA
0.13 | Correlation Coefficient |
Average diversification
The 3 months correlation between PCI and Ultimovacs is 0.13. Overlapping area represents the amount of risk that can be diversified away by holding PCI Biotech Holding and Ultimovacs ASA in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Ultimovacs ASA and PCI Biotech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on PCI Biotech Holding are associated (or correlated) with Ultimovacs ASA. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Ultimovacs ASA has no effect on the direction of PCI Biotech i.e., PCI Biotech and Ultimovacs ASA go up and down completely randomly.
Pair Corralation between PCI Biotech and Ultimovacs ASA
Assuming the 90 days trading horizon PCI Biotech is expected to generate 3.01 times less return on investment than Ultimovacs ASA. In addition to that, PCI Biotech is 1.24 times more volatile than Ultimovacs ASA. It trades about 0.03 of its total potential returns per unit of risk. Ultimovacs ASA is currently generating about 0.11 per unit of volatility. If you would invest 170.00 in Ultimovacs ASA on September 1, 2024 and sell it today you would earn a total of 28.00 from holding Ultimovacs ASA or generate 16.47% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 95.65% |
| Values | Daily Returns |
PCI Biotech Holding vs. Ultimovacs ASA
Performance |
| Timeline |
| PCI Biotech Holding |
| Ultimovacs ASA |
PCI Biotech and Ultimovacs ASA Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with PCI Biotech and Ultimovacs ASA
The main advantage of trading using opposite PCI Biotech and Ultimovacs ASA positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if PCI Biotech position performs unexpectedly, Ultimovacs ASA can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ultimovacs ASA will offset losses from the drop in Ultimovacs ASA's long position.| PCI Biotech vs. DnB ASA | PCI Biotech vs. Sparebank 1 SMN | PCI Biotech vs. Norsk Hydro ASA | PCI Biotech vs. Equinor ASA |
| Ultimovacs ASA vs. Bergenbio ASA | Ultimovacs ASA vs. Nykode Therapeutics ASA | Ultimovacs ASA vs. PCI Biotech Holding |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.
Other Complementary Tools
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio |